Close

Teva Pharma (TEVA) Launches Generic Gleevec Tablets in U.S.

August 5, 2016 8:05 AM EDT Send to a Friend
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of the generic equivalent to Gleevec®1(imatinib mesylate) tablets,100 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login